Sort   by:  
 Page size 
UnknownAssociation of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression.
Not available
S-EPMC3360116 | biostudies-literature
UnknownCYP4F2 genetic variant alters required warfarin dose.
Not available
S-EPMC2288721 | biostudies-literature
UnknownPTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
Not available
S-EPMC4788379 | biostudies-literature
UnknownGenetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
Not available
S-EPMC3759580 | biostudies-literature
UnknownWarfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.
Not available
S-EPMC2865873 | biostudies-literature
UnknownGene-centric meta-analyses for central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations.
Not available
S-EPMC3988452 | biostudies-literature
UnknownEstimation of the warfarin dose with clinical and pharmacogenetic data.
Not available
S-EPMC2722908 | biostudies-literature
UnknownLarge-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
Not available
S-EPMC3309185 | biostudies-literature
UnknownGene-centric meta-analyses of 108 912 individuals confirm known body mass index loci and reveal three novel signals.
Not available
S-EPMC3522401 | biostudies-literature
UnknownLarge-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
Not available
S-EPMC3487124 | biostudies-literature
Sort   by:  
 Page size